WallStSmart
MHUA

Meihua International Medical Technologies Co Ltd

NASDAQ: MHUA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$7.61
+0.00% today

Updated 2026-06-03

Market cap
$425.43M
P/E ratio
0.25
P/S ratio
4.75x
EPS (TTM)
$31.00
Dividend yield
52W range
$2 – $64
Volume
0.1M

Meihua International Medical Technologies Co Ltd (MHUA) Financial statements

SEC filings — annual and quarterly data.

Profit margin
11.19%
Operating margin
14.77%
ROE
8.43%
ROA
3.94%
Debt/equity
0.07x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2018$75.71M$15.48M42.12%25.33%20.44%
2019$79.63M$15.43M40.45%24.35%19.38%
2020$89.06M$19.05M41.72%26.35%21.38%
2021$104.04M$19.99M38.26%24.32%19.22%
2022$103.35M$6.24M36.86%10.45%6.04%
2023$97.10M$11.63M34.08%15.11%11.97%
2024$96.91M$10.84M34.36%14.77%11.19%

Frequently asked questions

What is Meihua International Medical Technologies Co Ltd's revenue?

Meihua International Medical Technologies Co Ltd's trailing twelve-month revenue is $89.55M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is MHUA?

In its most recent fiscal year, MHUA ran a gross margin of 34.36%, an operating margin of 14.77%, and a net margin of 11.19%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does MHUA generate?

MHUA produced $14.50M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MHUA's balance sheet healthy?

MHUA holds $15.96M in cash and equivalents against — in long-term debt, on $158.98M of shareholder equity. That debt is best read against the cash flow the business throws off each year.